Ru Liu‐Bryan
Impact in
- Rheumatology top 0.2%
- Osteoarthritis Treatment and Mechanisms
- Nephrology top 0.5%
- Gout, Hyperuricemia, Uric Acid
Papers in
-
- Inflammasome and immune disorders 16
- Peroxisome Proliferator-Activated Receptors 7
- Nephrology 21
- Gout, Hyperuricemia, Uric Acid 21
- Co-authors
- Robert Terkeltaub (35 shared papers)Martin Lotz (10 shared papers)Yun Wang (7 shared papers)David M. Rose (4 shared papers)Christopher K. Glass (2 shared papers)Matthew Nguyen (1 shared paper)Alan Jenn (1 shared paper)Peter Scott (1 shared paper)
- Journals
- Osteoarthritis and Cartilage (14 papers)Arthritis & Rheumatology (6 papers)The Journal of Immunology (4 papers)Arthritis Research & Therapy (4 papers)Annals of the Rheumatic Diseases (3 papers)
- Partner nations
- United StatesFranceSpain
In The Last Decade
Ru Liu‐Bryan
62 papers receiving 4.9k citations
Ru Liu‐Bryan's Hit Papers
Peers
Comparison fields: 5 of 123
- Rheumatology 1.8k
- Nephrology 855
- Immunology 1.1k
- Pharmacology 637
- Cancer Research 529
Countries citing papers authored by Ru Liu‐Bryan
This map shows the geographic impact of Ru Liu‐Bryan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ru Liu‐Bryan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ru Liu‐Bryan more than expected).
Fields of papers citing papers by Ru Liu‐Bryan
This network shows the impact of papers produced by Ru Liu‐Bryan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ru Liu‐Bryan. The network helps show where Ru Liu‐Bryan may publish in the future.
Co-authors
The 25 scholars most cited alongside Ru Liu‐Bryan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 64 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | A Subpopulation of Macrophages Infiltrates Hypertrophic Adipose Tissue and Is Activated by Free Fatty Acids via Toll-like Receptors 2 and 4 and JNK-dependent Pathways Hit paper breakdown → | 2007 | 815 |
| 2 | Emerging regulators of the inflammatory process in osteoarthritis Hit paper breakdown → | 2014 | 512 |
| 3 | 2005 | 326 | |
| 4 | 2009 | 249 | |
| 5 | 2015 | 235 | |
| 6 | 2020 | 206 | |
| 7 | 2005 | 192 | |
| 8 | 2016 | 181 | |
| 9 | 2019 | 174 | |
| 10 | 2013 | 145 | |
| 11 | 2011 | 142 | |
| 12 | 2009 | 128 | |
| 13 | 2006 | 128 | |
| 14 | 2010 | 116 | |
| 15 | 2014 | 97 | |
| 16 | 2014 | 94 | |
| 17 | 2018 | 93 | |
| 18 | 2015 | 91 | |
| 19 | 2013 | 83 | |
| 20 | 2014 | 77 |
About Ru Liu‐Bryan
Ru Liu‐Bryan is a scholar working on Molecular Biology, Nephrology, Rheumatology, Immunology and Epidemiology, having authored 64 papers that have together received 5.0k indexed citations. Recurring topics across this work include Gout, Hyperuricemia, Uric Acid (21 papers), Inflammasome and immune disorders (16 papers), Osteoarthritis Treatment and Mechanisms (15 papers), Adipose Tissue and Metabolism (8 papers), Immune Response and Inflammation (7 papers), Peroxisome Proliferator-Activated Receptors (7 papers), Cancer-related molecular mechanisms research (5 papers) and Inflammatory mediators and NSAID effects (5 papers). The work is most often cited by research in Rheumatology (1.8k citations), Nephrology (855 citations), Immunology (1.1k citations), Pharmacology (637 citations) and Cancer Research (529 citations). Ru Liu‐Bryan has collaborated with scholars based in United States, France and Spain. Frequent co-authors include Robert Terkeltaub, Martin Lotz, Yun Wang, David M. Rose, Christopher K. Glass, Matthew Nguyen, Alan Jenn, Peter Scott, Jerrold M. Olefsky and Donna Reichart. Their work appears in journals such as Osteoarthritis and Cartilage, Arthritis & Rheumatology, The Journal of Immunology, Arthritis Research & Therapy and Annals of the Rheumatic Diseases.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.